Issue 46, 2005
From the journal:

Chemical Communications

Tumor angiogenic vasculature targeting with PAMAM dendrimer–RGD conjugates†

Rameshwer Shukla,a   Thommey P. Thomas,a   Jennifer Peters,a   Alina Kotlyar,a   Andrzej Myca  and  James R. Baker, Jr.*a  

* Corresponding authors

a Michigan Nanotechnology Institute for Medicine and Biological Science, Department of Internal Medicine, Division of Allergy, University of Michigan, 9220 MSRB III, Box 0648, Ann Arbor, MI 48109, USA
E-mail: jbakerjr@umich.edu

Abstract

PAMAM dendrimer–RGD-4C peptide conjugate was synthesized and in vitro targeting efficacy to integrin receptor expressing cells was studied by flow cytometry and confocal microscopy.

Graphical abstract: Tumor angiogenic vasculature targeting with PAMAM dendrimer–RGD conjugates

About
Cited by
Related
Download options Please wait...

Supplementary files

Article information

DOI
https://doi.org/10.1039/B507350B
Article type
Communication
Submitted
01 Jun 2005
Accepted
12 Sep 2005
First published
10 Oct 2005

Chem. Commun., 2005, 5739-5741

Permissions

Request permissions

Tumor angiogenic vasculature targeting with PAMAM dendrimer–RGD conjugates

R. Shukla, T. P. Thomas, J. Peters, A. Kotlyar, A. Myc and J. R. Baker, Jr., Chem. Commun., 2005, 5739 DOI: 10.1039/B507350B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements